dependencies is currently developing at an unsurpassed speed, and
the pace will most likely increase even more in the very near future.
The fuel is provided by the accomplishment of the HUGO-project,
by the development of molecular genetics and modern molecular
biological techniques, by the rapid development of neuroscience in
general and psychoneuropharmacology in particular, and, not the
least, by the encouraging findings that it is indeed possible to reduce
alcohol consumption and craving in humans by means of specific
pharmacological interventions.
efforts of alcohol researchers all over the world, including the
members of the European Society for Biomedical Research on
Alcoholism (ESBRA), and bits and pieces to the puzzle will be
provided from many different scientific disciplines. One of the main
tasks of the near future will be to link the findings obtained at the
molecular, genetic level to behaviorally relevant manifestations at
the systemic level and transform this knowledge into effective
pharmacological treatment principles in the patient.
Pharmacological Treatments of Alcoholism – from Genes to
Patients” – will be devoted to this process by providing a scientific
state-of-the-art programme including both genetic and functional
aspects of the interdisciplinary enigma of alcohol dependence and
abuse. You are hereby cordially invited to participate in this event.
Welcome to Göteborg
RAboardmembers
President:
ChristerAlling,
Lund,Sweden
Secretary:
OttoLesch
Wien,Austria
FounderPresident:
RogerNordmann,
Paris,France
VicePresident:
HelmutSeitz
Heidelberg,Germany
Treasurer:
TomásZima
Prague,CzechRepublic
PastPresident:
PhilippeDeWitte
Louvain-la-Neuve,Belgium
FrançoiseBeaugé
Criteil,France,
JonathanChick
Edinburgh,Scotland,
GiancarloColombo
Cagliari,Italy,
ConsueloGuerri
Valencia,Spain,
MikkoSalaspuro
Helsinki,Finland
